MBBS (Hons), FCICM, FRACP, PGDipEcho Claire is a senior intensive care specialist, and became Director of ICU in 2020. Originally from Tasmania, Claire completed her medical degree in Hobart in 1999. After training at both The Alfred and Barwon Health, Claire began work as a Specialist in Barwon Health ICU in 2009. Major clinical projects include developing the Paediatric ICU program in University Hospital Geelong. Her work in this area was a significant factor in UHG being awarded the Victorian Premier’s Health Care Secretary Award for Improving Patient Outcomes and Patient Experience in 2014. Claire has a strong interest in education, having involvement with Deakin University, and ICU Supervisor of Training. Claire is also involved in Quality and Safety activities and is current Chair of the Blood and Blood Products Committee.
Clinical leadership
Claire became Director of Intensive Care at University Hospital Geelong in 2020. She has undertaken the Harvard Emerging Women Executives in Health Care Program, and is Chair of the Barwon Health Blood and Blood Products Committee, and led the development of the Barwon Health Paediatric Critical Care Program from 2011-2018.
Latest news:
-
Monday, May 16, 2022 - 15:59
JAMA COVI-PRONE no difference in endotracheal intubation or secondary outcomes in 400 patients who were not intubated and had confirmed or suspected COVID-19, when randomised to awake prone positioning compared with usual care. Posthoc analysis raised the possibility that patients with a PF ratio greater than 150 may benefit from prone ventilation.
Monday, May 16, 2022 - 14:42JC: JAMA FIRST-ABC Step-Down RCT critically ill children requiring noninvasive respiratory support following extubation, HFNC compared to CPAP post extubation failed to meet noninferiority criterion for time to liberation from respiratory support ( 50.5 hours HFNC vs 42.9 hours CPAP. 1-sided 97.5% CI for HR was 0.70, failed to meet the noninferiority margin of 0.75)
Monday, May 16, 2022 - 13:26JC: JAMA early tracheostomy (median D4 MV) vs standard (D11) in 382 adults receiving MV after acute, severe stroke, not associated improved outcomes, specifically favourable mRS (adj OR favourable outcome 0.93 95% CI 0.6-1.42, p=0.73)
Monday, May 16, 2022 - 11:59NEJM- The opportunities to become proficient at neonatal intubation are decreasing. Does peri-intubation high flow nasal oxygen decrease hypoxia and increase first-pass success? In 202 neonates, successful 1st attempt intubation without physiological instability occurred in 50% (HF) vs 31.5% (SC), RD 17.6%, 95% cI 6.0-29.2, NNT 6.
Monday, May 16, 2022 - 10:52JC: No diff 90-day neurological outcomes between patients transported to a local stroke center first vs directly to a thrombectomy-capable referral center in patients with suspected large-vessel occlusion acute ischemic stroke